December 15, 2021 09:51 AM ESTUpdated 10:47 AM
Coronavirus

US paus­es dis­tri­b­u­tion of GSK/Vir's Covid mAb not due to Omi­cron, but greater sup­ply of Eli Lil­ly mAbs

Zachary Brennan

Senior Editor

The US gov­ern­ment is shift­ing its dis­tri­b­u­tion of mAb in­fu­sions to fight the coro­n­avirus, de­cid­ing to go from sup­ply­ing tens of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

No­vo turns to Septer­na for oral obe­si­ty med­i­cines in deal worth up to $2.2B

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

Ad­vo­ca­cy groups and ex­perts call for decade-long ban on germline edit­ing

CRISPR patent spat re­vived by fed­er­al ap­peals court rul­ing

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

A service from the Financial Times